To assess the relation between increases in contractile function and oxygen consumption (Vo2) during increased coronary flow (Gregg's phenomenon), we the energetic cost for the increase in mechanical function is unclear.
end, we used the Vo2-PVA relation as a tool to relate ventricular mechanics to energetics. In addition, to separate the effect of increased coronary flow from that of increased perfusion pressure, we induced coronary hyperemia with adenosine while keeping perfusion pressure constant.
Materials and Methods Heart Preparation
Experiments were performed on the isolated, crosscirculated (blood-perfused) rabbit heart supported by anesthetized intact rabbits. The details of the surgical procedure have been described elsewhere. 17, 18 In brief, four rabbits (one heart donor, one blood donor, and two supporters) were premedicated with fentanyl (0.044 mg/kg i.m.) and droperidol (2.2 mg/kg i.m.), anesthetized with ketamine (20 mg/kg i.m.) and xylazine (1 mg/kg i.m.), tracheotomized, and ventilated with respirators (Harvard Apparatus, South Natick, Mass.). The anesthesia thereafter was maintained with supplemental intramuscular ketamine and xylazine. The chest of the heart donor rabbit (weight, 3.4+0.6 kg [mean±SD]) was then opened, and the innominate artery was cannulated and connected to the perfusion circuit. Heparinized (1,500 units/kg) arterial blood from the carotid arteries of the two support rabbits flowed to an arterial reservoir, from which the donor heart was perfused by a pump. Coronary venous blood draining from the right ventricle of the donor heart was returned to the external jugular veins of the support rabbits. The supported beating heart was excised from the chest cavity after cross-circulation was started, so that there was no interruption of the coronary circulation during the surgery. Mean coronary perfusion pressure was monitored and kept at a constant level between 80 and 110 mm Hg throughout each experiment.
To measure left ventricular pressure and volume, a thin latex balloon (unstretched volume, 4 ml) mounted on a Y-connector was placed in the left ventricle and secured with a purse-string suture around the mitral valve ring. Coronary blood flow was measured at the coronary venous drainage tube with a graduated cylinder by timed collection. The coronary arteriovenous oxygen content difference was measured continuously with an AVOX analyzer (A-VOX systems, San Antonio, Tex.) that was calibrated with a Lex 02 Con oxygen content analyzer (Lexington, Waltham, Mass.).
The temperature of the excised heart was maintained at 36-37°C. To maintain arterial pH, Po2, and Pco2 of the support rabbits within physiological ranges, supplemental oxygen was given or the respiratory rate was changed if necessary. In addition, indomethacin (1 mg/kg i.v.) was given to maintain mean arterial pressure of the support rabbits above 60 mm Hg.18 Experimental Protocol Experiments were performed on nine isolated nary perfusion pressure, electrocardiogram, left ventricular pressure, coronary blood flow, and coronary arteriovenous oxygen content difference were measured during steady-state isovolumic contractions. Left ventricular volume was then varied within a range between V0 (at which peak isovolumic pressure was zero) and an arbitrary maximal volume at which peak systolic pressure exceeded coronary perfusion pressure or diastolic pressure reached approximately 13 mm Hg. After approximately 3 minutes were allowed to elapse, measurements were repeated when ventricular pressure and arteriovenous oxygen content difference stabilized at each new ventricular volume. This set of measurements was termed the control run.
Adenosine was then infused into the coronary perfusion tubing with an infusion pump (Harvard) at a constant rate between 20 and 200 yg/min (mean, 79+±73 ,g/min). Coronary flow rate was increased with the pump to maintain perfusion pressure constant. Measurements were repeated in the same manner as the control run. This set of measurements was termed the adenosine run.
In four additional hearts, measurements before and during adenosine were made under ,l-blockade with propranolol to determine if increased delivery of catecholamines to the myocardium was responsible for the increased mechanical function and Vo2 observed with adenosine. Propranolol in a bolus dose of 40 jig was administered into the coronary perfusion tubing before the control measurements, followed by continuous infusion at a rate of 4 ,ug/min throughout the experiment. The rates of adenosine infusion in this series of experiments were 25 ,ug/min in two experiments and 50 gg/min in the other two experiments.
Heart rate was held constant by left atrial pacing throughout the experiment.
Data Analysis
End-systolic pressure-volume relation. Data were recorded on a pen recorder and stored on computer disk at a sampling interval of 5 msec for off-line data analysis with a PDP 11/73 computer (Digital Equipment Corp., Marlboro, Mass. by a third power of V-Vo.14 PVA (in mm Hg. ml beat-1.100 g-') was normalized for left ventricular weight.
The relation between left ventricular Vo2 and PVA was obtained in each run. Linear regression analysis was used to determine the slope (in ml 02*mm Hg-1 ml-1) and the Vo2-intercept (in ml 02-beat-1.100 g-1) of each Vo2-PVA relation.
Contractile efficiency. PVA is theoretically an expression of total mechanical energy and has the dimensions of energy because 1 mm HgmlI=1.33x10-4 J. Also, under normal aerobic conditions, 1 ml 02 consumed by myocardium is approximately equivalent to 20 J.15 Therefore, both Vo2 (ml 02-beat-1.100 g-') and PVA (mm Hg-ml-beat-1.100 g-') can be converted into the same unit of energy (J.beat-1100 g-1). Thus, the dimensionless ratio of PVA to excess Vo2 above the unloaded V02 is the fraction of total mechanical energy output to energy input that is used exclusively for mechanical contraction, which reflects the chemomechanical energy transduction efficiency of the contractile machinery, or contractile efficiency.15 This contractile efficiency was estimated as the reciprocal of the slope of the linear Vo2-PVA relation.1718
Oxygen cost of contractility. Enhancement of myocardial contractility increases the oxygen cost of excitation-contraction coupling, while Vo2 for basal metabolism remains constant.14 Further, changes in E,,,, during a positive inotropic intervention linearly correlate with changes in the Vo2-intercept of the Vo2-PVA relation.21 Therefore, in the absence of a change in the slope of the Vo2-PVA relation, the ratio of an increase in the Vo2-intercept to an increase in Emax can be considered a measure of the oxygen cost of increased contractility. 22 The effect of increased coronary flow with adenosine on the oxygen cost of increased Em was assessed as A%Vo2-intercept/1A%Emax and compared with reported values with other inotropic interventions in the literature.
Statistics
Comparisons of paired variables before and during adenosine infusion were performed by paired t test. The slopes and intercepts of the end-systolic pressure-volume relation and Vo2-PVA relation before and during adenosine infusion were also compared by paired t test on the assumption that the slope and intercept values of individual regression lines reasonably represented their true values because the correlation coefficients were close to unity in every heart. In addition, analysis of covariance23 was performed to assess slope and elevation differences between the two Vo2-PVA relations before and during adenosine. A value ofp<0.05 was considered statistically significant. Data are presented as mean±SD unless otherwise indicated.
Results

Hearts Without [3-Blockade
In the nine experiments without /-blockade, left and right ventricular weight averaged 4.4±0.6 and 1.4+0.3 g, respectively. Heart rate was kept constant at 174+25 beats.min-1 and mean coronary perfusion pressure was kept constant at 93+± 11 mm Hg in the control run and 93 + 10 mm Hg in the adenosine run. Coronary blood flow varied slightly according to changes in ventricular loading conditions at a constant perfusion pressure. Mean coronary flow averaged 4.6+1.5 ml.min-1 or 0.79±0.21 ml.min-'g-1 during the control run, and 8.7+2.5 ml.min-1 or 1.52+0.50 ml.min-l g-1 during the adenosine run.
The increase in mean coronary blood flow during the adenosine run averaged 99.3+75.8% (p<0.01). Figure 1 shows recordings of perfusion pressure, electrocardiogram, left ventricular pressure, and coronary arteriovenous 02 difference during the control and adenosine run in one heart without ,8-blockade. During adenosine infusion at a constant perfusion pressure, coronary blood flow increased from 4 Figure  4A , p<0.01), whereas normalized V0 did not change significantly ( Figure 4B, 9 .8±2.8 versus 10.1±2.7 ml 100 g-1).
The Vo2-PVA relation was also highly linear in each heart: the median correlation coefficient of the nine hearts was 0.978 during the control run and 0.980 during the adenosine run. The slope of the Vo2-PVA relation did not change significantly with adenosine ( Figure 4C, 2 to 0.036+0.005 ml O2.beat-1.100 g-1 (or 0.73+0.11 JPbeat-1. 100 g-1) ( Figure 4D,p<0.01 ). Directly measured unloaded Vo2 also increased significantly by the same amount from 0.030±0.005 ml O2-beat-1 *100 g`1 (or 0.60±0.09 J beat`1.100 g-1) to 0.036±0.005 ml O2.beat-1.100 g`1 ( .
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Control Adeno utable to the increased coronary blood flow, resulting from coronary vasodilation by adenosine.
Hearts With -3-Blockade
In the four hearts studied under (3-blockade, heart rate was held constant at 159±10 beats/min, and mean coronary perfusion pressure was kept constant at 87+5 mm Hg during the control run and 85±8 mm Hg during the adenosine run. With adenosine infusion, average coronary blood flow increased significantly by 75.5+48.8% ( Figure 6A JPbeat-1.100 g-1] to 0.043±0.003 ml 02-beat-1.100 g-' [ Figure 6E and 6F) . Analysis of covariance indicated a significant upward shift of the Vo2-PVA relation during adenosine in all four hearts (all p<0.01), whereas it indicated no slope difference before and during adenosine. Thus, This conclusion is based on the following major findings: 1) increased coronary blood flow with adenosine at a constant perfusion pressure increases Ema,, 2) increased coronary blood flow increases the unloaded Vo2 without changing the slope of the Vo2-PVA relation, and 3) f8-adrenergic blockade does not eliminate these increases in Ema and unloaded Vo2.
Since Gregg8 observed that elevation of coronary perfusion pressure increases Vo2, there have been many reports of increased cardiac contractile and metabolic function during increased coronary perfusion pressure and flow.1-7,9-12 However, in most of these studies, both perfusion pressure and coronary flow were increased simultaneously, and therefore, the effect of increased perfusion pressure could not be separated from that of increased flow.1-3,6-10 In addition, previously observed enhancement of contractile and metabolic function with elevated perfusion pressure and flow may have been due to an improvement in underlying ischemic conditions, especially in the subendocardial layer,13 because hearts were perfused with crystalloid solution2,4-6 or the perfusion pressure was low (40-60 mm Hg) during control measurements.1,4,5,9,10,12 In contrast, our cross-circulated heart preparation is perfused with arterial blood from intact support animals at a constant, normal perfusion pressure, eliminating the possibility of ischemia during the control measurements.
Arnold et a14 claimed that perfusion pressure, rather than flow, is the primary determinant of Gregg's phenomenon, because increased coronary flow during hypoxia at a constant perfusion pressure did not increase either left ventricular systolic pressure or Vo2, whereas increased perfusion pressure during dextran administration at a constant flow did increase both left ventricular systolic pressure and Vo2. However, a negative inotropic effect of hypoxia itself might have masked increases in both contractile function and Vo2 during increased coronary flow, whereas an increase in intracellular calcium induced by the hypertonic dextran perfusate itself 24 might have enhanced systolic pressure and Vo2. In contrast, Abel and Reis1" considered coronary blood flow the independent determinant of contractile function and Vo2 because increased blood flow produced by nitroglycerin at a constant perfusion pressure increased both Vma. and Vo2, whereas decreased perfusion pressure with nitroglycerin at a constant blood flow did not change Vmax or Vo2. Although they did not assess ventricular contractility using Emax, their results are in accordance with ours.
The relation between increased contractile function and Vo2 during increased coronary flow has not been systematically analyzed previously. Although Miller et a17 observed that decreasing left ventricular volume to keep systolic pressure constant during increased coronary blood flow eliminated the increase in Vo2, they could not logically explain the mechanism. On the basis of our results, the observaeffects of a decrease in mechanical Vo2 caused by decreased PVA (decreased ventricular volume) and an increase in unloaded Vo2 (or nonmechanical Vo2) resulting from increased coronary flow. The present study demonstrates a constant contractile efficiency and a significant increase in unloaded Vo2 during increased coronary blood flow. The finding that contractile efficiency remained constant despite a significant increase in Ema. indicates that the chemomechanical energy transduction efficiency (excess Vo2 to PVA efficiency) of the contractile machinery15 did not change during increased coronary blood flow. This is in accordance with previous findings in which Emax was enhanced with calcium and epinephrine.14 Thus, following all acute positive or negative inotropic interventions tested to date, the contractile efficiency has not changed.15 In contrast, our previous study has demonstrated a decreased contractile efficiency in hyperthyroid rabbit hearts in which the myosin isoform component is chronically altered. 18 The increase in unloaded Vo2 with an increase in Emax is also in accordance with previous reports.' 4 Second, in the present study, pretreatment with propranolol did not suppress the increase in peak isovolumic pressure, Em,,, or V02 during increased coronary flow with adenosine. Thus, the possibility that increased delivery of circulating catecholamines from the support animal to the isolated heart, caused by increased coronary flow, results in an enhanced Emn is also remote.
Third, an increase in basal metabolism caused by increased flow is a possible mechanism for the increase in Vo2 during increased coronary flow. Gibbs and Kotsanas3' reported a linear dependence of Vo2 for basal metabolism on coronary blood flow. However, the magnitude of increased Vo2 caused by this mechanism (0.4-0.7 ml O2.min-1.100 g`1 for a 1 ml.min-1 g-' increase in flow)31 does not appear to be large enough to account for the total increase in Vo2 during increased coronary flow in the present study (1.34 ml O2-min-1.100 g`1 for a 0.73 ml min-1 g-1 increase in flow). In addition, this mechanism by itself does not explain the increase in mechanical function during increased coronary flow.
Fourth, there may be an increase in myocardial fiber length in the mid or outer layer of the ventricular wall when wall thickness increases during increased coronary flow at a constant chamber volume. In fact, an increase in ventricular wall thickness3233 or epicardial circumference34 has been observed during increased coronary flow. In addition, Poche et a135 reported an increase in sarcomere length with increases in coronary perfusion pressure and flow. This increase in sarcomere length should result in increases in both generated force and myocardial oxygen consumption via the Frank-Starling mechanism even at a constant inotropic state. To determine the potential role of this effect, we hypothesized a midwall fiber length model, assuming spherical geometry, which is presented in the "Appendix." This midwall model, by itself, explains about 71% of the increase in Vo2 at maximal measured left ventricular volume during increased coronary flow with adenosine but may not completely explain the parallelism of the two Vo2-PVA relation lines. Therefore, additional mechanisms may be needed to completely account for our results.
In this regard, Krams et a136 recently proposed that the time-varying elastance concept for the left ventricle20 also applies to the lumen of the coronary vasculature. If so, the left ventricular Emrn we measuredd could be a composite of the end-systolic elastance of both the left ventricular myocardium and the coronary vasculature. Adenosine preferentially dilates coronary microvessels (between arterioles <170 ,um in diameter and venules <150 gm in diameter),37 that is, capacitance vessels. Therefore, it is conceivable that adenosine increases the elastance of the coronary vasculature, leading to an increase in resultant left ventricular Em., This hypothesis merits further study.
Finally, Kitakaze and Marban38 recently reported an increase in the intracellular calcium transient during systole when coronary perfusion pressure and flow were elevated in isolated ferret hearts. A positive inotropic effect caused by increased intracellular calcium could explain both the parallel upward shift of the Vo2-PVA relation14 and the close agreement of the oxygen cost of Emax with increased coronary flow and calcium, which were observed in the present study. However, Kitakaze and Marban38 used a crystalloid-perfused heart preparation, in which coronary flow was unphysiologically high (3-7 ml g-1 min-1), coronary autoregulation was absent, and the magnitude of the increase in developed pressure (approximately 100% increase for doubled coronary flow) was remarkably larger than that observed in our blood-perfused heart preparation (only a 19% increase in peak systolic pressure for doubled coronary flow). More importantly, the primary mechanism of the increase in intracellular calcium transients during increased coronary flow remains obscure. For example, an increase in fiber length in the mid to outer layer might result in an increase in intracellular calcium transients.39 Alternatively, there could be a direct, flow-induced increase in intracellular calcium concentration, such as that observed in endothelial cells. 40 Further study will be needed to determine the primary mechanism responsible for the increase in mechanical and metabolic function during increased coronary blood flow under more physiological conditions. Appendix Figure During adenosine administration, midwall fiber length would increase because of an increased yen- Assuming that the radius (r) to wall thickness (h) ratio is 1 (i.e., r=h), an increase in wall thickness (h') during a 3.8% increase in midwall circumference can be calculated from the equation [r+(h+h')/2]/(r+h/ 2)=1.038, yielding an incremental ratio h'/h=0.114. This value is very close to the reported value of an increase in wall thickness (9-11%)33 during increased coronary blood flow. Thus, it seems realistic that an 11.4% increase in wall thickness results in a 3.8% increase in midwall circumference, a 20% increase in E~, and a 44% increase in PVA in the midwall fiber length model.
In the Vo2-PVA diagram ( Figure Al , lower panel), PVA of the real ventricle increased by approximately 20% from PVAc to PVAA, and Vo2 increased from Vo2C to VO2A during increased coronary blood flow. Thus, the operating point moved from point C to A, resulting in an upward shift of the Vo2-PVA relation line. However, with the midwall model, the operating point would move from point C to B along the control Vo2-PVA relation line with some additional increase in Vo2 for basal metabolism.
Because control PVA at maximal measured left ventricularvolume was 563 mm Hg ml beat-1 100 g-1, and the slope of the control Vo2-PVA relation was 2.2x 10-5 ml 02 mm Hg`.ml-1 in the present study, a 44% increase in PVA amounts to 0.0055 ml 02.beat-1.100 g`. Thus, the midwall model can explain 71% of the total increase in Vo2 (0.0077 ml 02.beat-1100 g-') observed during increased coronary blood flow with adenosine. The remaining portion of the increase in Vo2 cannot be explained by this midwall model and, hence, can be attributed to other factors, for instance, an increase in basal metabolism31 or an error caused by the assumption of spherical geometry.
One confounding point of this hypothesis is that at a low ventricular volume range, the amount of increase in midwall PVA would not be large enough to explain the increase in Vo2 during adenosine. If the increase in PVA is smaller in a low ventricular volume range, the resultant Vo2-PVA relation line during increased coronary blood flow would have a higher slope value than the control line. Thus, some other mechanism may be required to explain the parallelism of the two Vo2-PVA relations.
